All
FDA mandates new labels for anti-fungals
June 1st 2001Miami - The FDA last month issued a health warning concerning two popular anti-fungal drugs used to treat onychomycosis, requiring that labels for Sporanox (Janssen Pharmaceuticals) and Lamisil (Novartis) carry stronger warnings about potential liver damage. Sporanox also must warn against potential heart disease, the administration said.
President-elect stalls in court
June 1st 2001Miami - At press time, a federal court here was waiting for briefs on closing arguments from lawyers representing the board of directors of the American Academy of Dermatology regarding its invalidation of the election of Sorrel S. Resnik, M.D., to the position of president-elect 2001.
Antiviral vaccine rebounds versus herpes
June 1st 2001Washington - A glycoprotein vaccine has induced significant protection against genital herpes disease in women with no evidence of either herpes simplex virus 1 or HSV 2 infection, said Stephen K. Tyring, M.D., Ph.D., at the annual meeting of the American Academy of Dermatology.
5-FU cream formulation displays unique profile
June 1st 2001Washington - The new 5-fluorouracil (5-FU) 0.5 percent topical cream (Carac) indicated for the treatment of actinic keratoses offers more targeted drug delivery along with the potential for a more favorable safety profile than a previously available formulation containing a 10-fold higher concentration of active ingredient, according to results from comparative studies presented at the annual meeting of the American Academy of Dermatology.
Expanding field boosts interest in fillers
May 1st 2001Washington - A resurgence of interest in the use of fillers as a minimally invasive cosmetic surgery technique has been accompanied by dramatic growth in the number of products available for soft tissue augmentation, Arnold W. Klein, M.D., said at the annual meeting of the American Academy of Dermatology.
Combo of biological vaccine, chemo looks promising in early tests
May 1st 2001New York - Combining biological vaccines with chemotherapy after surgery may increase life expectancies for patients in the most critical stages of melanoma, according to Steven O' Day, M.D., John Wayne Cancer Institute, Santa Monica, Calif.
Sensitive skin, allergic reactions concern in topical product selection
May 1st 2001Maui, Hawaii - Rosacea patients and the dermatologists who treat them should be especially mindful of the ingredients found in topical products because they may be a source of significant cutaneous reactions, S. Manjula Jegasothy, M.D., said at the 25th annual Hawaii Dermatology Seminar.
Study refutes 'conventional' dose griseofulvin in tinea capitis Tx
May 1st 2001Lubbock, Texas - Results of a retrospective study evaluating recurrence rates following successful griseofulvin treatment for tinea capitis confirm what most dermatologists knew from their clinical experience - that the dose of griseofulvin used to treat this fungal infection should be at least 20 mg/kg/day.
Combination therapy cost-effective for treating severe onychomycosis
May 1st 2001Washington - In patients with severe toenail onychomycosis, combination topical and systemic antifungal therapy - consisting of locally applied amorolfine 5 percent nail lacquer plus oral terbinafine or itraconazole - improves response rates and is more cost-effective compared with oral treatment alone, according to research presented at the annual meeting of the American Academy of Dermatology.
United we subspecialties should stand
May 1st 2001Dear Editor: I am writing to express my concerns and disappointment about Dr. Norman Levine's editorial comments published in the March issue of Dermatology Times ("The elephant in our living room: What is happening to dermatology?"). As co-chairman of the section on communications for the American Academy of Dermatology, no one is more acutely aware of the changing trends in dermatology than I am. Each time we consider implementing a new communications program for the academy, we must consider the interest of the entire membership. This, of course, has become increasingly difficult over the years due to the fact that our specialty now encompasses medically, surgically, and cosmetically oriented dermatologists.
Academy stands by election decision
May 1st 2001Dear Editor: I am writing in response to the front-page article in your February 2001 issue ("AAD upholds decision to invalidate election"), which reports on the decision of the American Academy of Dermatology (AAD) board of directors to set aside the results of the election for the position of president-elect for 2001.
Derms warned of state regulations
May 1st 2001Washington - Efforts to regulate office-based surgery and require surgeons who perform cosmetic surgery to have additional credentials will require dermatologists across the country to carefully monitor state legislatures and medical boards, several speakers said at the annual meeting of the American Academy of Dermatology.
Early response, access to equipment key to in-office ACLS
January 1st 2001Dallas - Acting quickly to help patients in need of advanced cardiaclife support is of the most importance, stressed Marc E. Boddicker, M.D.,during the annual joint meeting of the American Society for DermatologicSurgery and the American College of Mohs Micrographic Surgery and CutaneousOncology.
WDS, Al Roker team up for television special on ethnic skin
May 22nd 8San Francisco - The Women's Dermatologic Society (WDS) is teaming up with Al Roker to educate and inform the public with a television program called "America’s Ethnic Skin: An Al Roker Special". The program airs on NBC May 24, PRNewswire reports.
Skinvisible signs licensing agreement for two acne products
May 17th 8Las Vegas - Skinvisible, a research and development company focused on dermatology products, has signed a licensing agreement with Embil Pharmaceutical Co. for the right to develop and market two acne products, Earthtimes.org reports.